Korsana Biosciences, Inc. (KRSA)
32.83
-2.16
(-6.17%)
USD |
NASDAQ |
Sep 21, 16:00
33.09
+0.26
(+0.79%)
After-Hours: 20:00
Korsana Biosciences Shareholders Equity (Quarterly) : 5.087M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.087M |
| March 31, 2026 | 6.791M |
| December 31, 2025 | 9.085M |
| September 30, 2025 | 9.538M |
| June 30, 2025 | 8.57M |
| March 31, 2025 | 8.78M |
| December 31, 2024 | 8.85M |
| September 30, 2024 | 8.198M |
| June 30, 2024 | 8.783M |
| March 31, 2024 | 9.923M |
| December 31, 2023 | 11.29M |
| September 30, 2023 | 12.87M |
| June 30, 2023 | 5.15M |
| March 31, 2023 | 3.925M |
| December 31, 2022 | 10.45M |
| September 30, 2022 | 16.52M |
| June 30, 2022 | 25.36M |
| March 31, 2022 | 37.03M |
| Date | Value |
|---|---|
| December 31, 2021 | 48.25M |
| September 30, 2021 | 56.39M |
| June 30, 2021 | 65.22M |
| March 31, 2021 | 48.43M |
| December 31, 2020 | 59.49M |
| September 30, 2020 | 75.35M |
| June 30, 2020 | 66.10M |
| March 31, 2020 | 81.54M |
| December 31, 2019 | 97.73M |
| September 30, 2019 | 119.20M |
| June 30, 2019 | 141.19M |
| March 31, 2019 | -7.752M |
| December 31, 2018 | -10.44M |
| September 30, 2018 | -8.12M |
| June 30, 2018 | -8.609M |
| March 31, 2018 | |
| December 31, 2017 | -8.567M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Climb Bio, Inc. | 239.55M |
| Q32 Bio, Inc. | 105.90M |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.93M |
| Total Liabilities (Quarterly) | 1.843M |
| Current Ratio | 0.8215 |